Aspirin

In a pooled cohort of the two STOPDAPT-2 trials, among patients who underwent PCI, switching from dual antiplatelet therapy to clopidogrel monotherapy after 1 month reduced bleeding risk compared with 12-month DAPT.

In a subgroup analysis of MASTER-DAPT, regardless of whether patients had a history of MI, 1-month DAPT after PCI was noninferior to 3-month or longer DAPT for ischemic events and conferred a reduction in bleeding events.

Healio and Cardiology Today have compiled a list of the most-read cardiology news of October 2021.

Xarelto was superior to aspirin for lowering the risk for recurrent stroke or systemic embolism among individuals with left ventricular dysfunction, according to results of a post hoc exploratory analysis of a randomized clinical trial.

In pediatric patients undergoing the Fontan procedure, those assigned rivaroxaban had numerically lower but statistically similar rates of thrombotic events compared with those assigned aspirin, according to results of the UNIVERSE trial.

The U.S. Preventive Services Task Force recently issued a draft recommendation that states the task force no longer recommends aspirin for primary CVD prevention in adults aged 60 years and older.

Many patients undergoing transcatheter aortic valve replacement have multiple thrombotic and bleeding-related comorbidities that make optimal antiplatelet and anticoagulant management complex, leaving the question of which strategies are best open to debate.

The U.S. Preventive Services Task Force no longer recommends aspirin for primary CVD prevention in adults aged 60 years or older, according to a draft recommendation issued today.

Long-term ticagrelor monotherapy after PCI lowered risk for bleeding compared with 1-year dual antiplatelet therapy followed by 1-year aspirin monotherapy in patients with ACS, but not for those with CAD.

The U.S. Preventive Services Task Force said it was maintaining a stance it took in 2014 and recommended the use of low-dose aspirin to prevent preeclampsia after 12 weeks of pregnancy in women who are at high risk for the condition.